China Tian Yuan Healthcare Group Ltd. reported its interim results for the six months ended 30 June 2025. The group recorded revenue of HK$8.4 million, down from HK$14.9 million for the same period in 2024. Cost of sales declined to HK$0.3 million from HK$5.0 million in the prior-year period. Gross profit for the first half of 2025 was HK$8.1 million, compared to HK$9.9 million a year earlier. The company reported a net loss from operating activities of HK$3.9 million, an improvement from the HK$7.4 million net loss recorded in the first half of 2024. Administrative expenses increased to HK$17.4 million from HK$14.6 million, while finance costs decreased slightly to HK$1.5 million from HK$1.6 million in the prior year. The group recorded a reversal of expected credit loss amounting to HK$2.5 million, compared to HK$0.4 million in the previous period. Other net gains totaled HK$2.8 million, reversing a net loss of HK$3.1 million in the year-ago period. The share of losses of associates was HK$0.1 million, compared to HK$0.02 million in the previous period. No outlook or guidance was provided in the interim financial report.